KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Inventory (2016 - 2025)

Historic Inventory for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $186.0 million.

  • Quest Diagnostics' Inventory rose 108.7% to $186.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.0 million, marking a year-over-year increase of 108.7%. This contributed to the annual value of $188.0 million for FY2024, which is 105.26% down from last year.
  • Quest Diagnostics' Inventory amounted to $186.0 million in Q3 2025, which was up 108.7% from $187.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Inventory high stood at $223.0 million for Q1 2021, and its period low was $181.0 million during Q1 2024.
  • For the 5-year period, Quest Diagnostics' Inventory averaged around $191.5 million, with its median value being $188.0 million (2024).
  • Its Inventory has fluctuated over the past 5 years, first surged by 7698.41% in 2021, then tumbled by 1165.92% in 2022.
  • Quest Diagnostics' Inventory (Quarter) stood at $208.0 million in 2021, then dropped by 7.69% to $192.0 million in 2022, then decreased by 1.04% to $190.0 million in 2023, then decreased by 1.05% to $188.0 million in 2024, then decreased by 1.06% to $186.0 million in 2025.
  • Its Inventory stands at $186.0 million for Q3 2025, versus $187.0 million for Q2 2025 and $189.0 million for Q1 2025.